Samlyn Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-197,925
| Closed | -$23.8M | – | 98 |
|
|
2024
Q1 | $23.8M | Sell |
197,925
-424,251
| -68% | -$51.1M | 0.4% | 68 |
|
|
2023
Q4 | $76.5M | Sell |
622,176
-736,645
| -54% | -$90.6M | 1.52% | 22 |
|
|
2023
Q3 | $176M | Buy |
1,358,821
+12,591
| +0.9% | +$1.63M | 2.88% | 8 |
|
|
2023
Q2 | $167M | Buy |
1,346,230
+557,605
| +71% | +$69.1M | 2.83% | 6 |
|
|
2023
Q1 | $115M | Buy |
788,625
+166,789
| +27% | +$24.4M | 2.09% | 14 |
|
|
2022
Q4 | $99.1M | Sell |
621,836
-421,479
| -40% | -$67.1M | 1.94% | 16 |
|
|
2022
Q3 | $139M | Sell |
1,043,315
-160,244
| -13% | -$21.4M | 2.58% | 10 |
|
|
2022
Q2 | $188M | Buy |
1,203,559
+264,146
| +28% | +$41.2M | 3.75% | 6 |
|
|
2022
Q1 | $146M | Buy |
939,413
+283,744
| +43% | +$44.2M | 2.1% | 11 |
|
|
2021
Q4 | $83.5M | Buy |
655,669
+132,383
| +25% | +$16.9M | 1.15% | 26 |
|
|
2021
Q3 | $68.1M | Buy |
523,286
+191,253
| +58% | +$24.9M | 0.91% | 31 |
|
|
2021
Q2 | $59M | Buy |
332,033
+131,614
| +66% | +$23.4M | 0.87% | 31 |
|
|
2021
Q1 | $32.9M | Buy |
+200,419
| New | +$32.9M | 0.45% | 53 |
|